Cannabis News and Research

Latest Cannabis News and Research

Study sheds light on common adverse reactions to cannabis

Coughing fits, anxiety and paranoia are three of the most common adverse reactions to cannabis, according to a recent study by Washington State University researchers.

30 Mar 2020

Handy homogeniser for cannabis sample preparation

The Chromatrap Spin Column Homogeniser from Porvair Sciences is gaining considerable interest from organizations preparing Cannabis samples for analysis of Tetrahydrocannabinol and Cannabidiol.

From Chromatrap® - Porvair Sciences Ltd 30 Mar 2020

Study shows legal marijuana products too strong for pain relief

Most legal marijuana products supplied to medical dispensaries are stronger than recommended for treatment of chronic pain.

26 Mar 2020

Accurate and informative labeling of CBD products is a critical public health issue

The need for accurate and informative labeling of hemp and hemp-derived cannabidiol (CBD) products is a critical public health issue.

25 Mar 2020

Mapping the cannabis genome to improve agriculture and human health

Unlocking the full potential of cannabis for agriculture and human health will require a co-ordinated scientific effort to assemble and map the cannabis genome, says a just-published international study led by University of Saskatchewan researchers.

25 Mar 2020

Vaporized cannabis increases drug-seeking behavior, study shows

Rats with regular access to cannabis seek more of the substance and tend to show increased drug-seeking behavior when cannabis is absent.

24 Mar 2020

Cannabidiol helps fight antibiotic-resistant bacteria

Since the discovery of penicillin in 1928 by Sir Alexander Fleming, antibiotics have saved millions of lives from fatal infections world-wide. However, with time bacteria have developed mechanisms to escape the effects of antibiotics - they have become resistant.

24 Mar 2020

Using cannabinoids for management of acute pain

A new systematic review and meta-analysis showed a small but significant reduction in subjective pain scores for cannabinoid treatment compared to placebo in patients experiencing acute pain.

23 Mar 2020

Why is the tobacco industry supporting wider access to medical cannabis?

A new study published in the BMJ reveals disturbing connections between organizations and groups that are lobbying for broader access to medical cannabis and those who are fighting for the legalization of recreational cannabis. This raises questions as to the reasons behind the industry’s support for measures that will make it easier for patients to gain access to medical cannabis – is it because of the knowledge that by so doing, they will also be able to market the drug for recreational use in the UK?

18 Mar 2020

UCLA researcher awarded NIH grant to study pain-relieving effects of cannabis chemicals

Ziva Cooper, research director of the UCLA Cannabis Research Initiative, has been awarded a $3.9 million grant from the National Center for Complementary and Integrative Health at the NIH to study whether cannabis chemicals called terpenes can reduce the amount of opioid medication a person needs to reduce pain.

18 Mar 2020

How effective is Gabapentin in alcohol use disorder?

A new study published in the journal JAMA Internal Medicine in March 2020 reports the striking efficacy of the drug gabapentin in helping people with alcohol use disorder (AUD) with their alcohol withdrawal symptoms.

9 Mar 2020

Study looks at lung injury and vaping THC and vitamin E acetate

The US has witnessed a spate of patients presenting with acute lung injury associated with e-cigarettes or vaping product use. A new study published in the journal JAMA Internal Medicine shows the pattern of the outbreak in California where recreational cannabis use is legal and which has among the maximum cases of the strange illness.

8 Mar 2020

Fears prevent vaping to help smokers to quit

According to a new report from the Public Health England (PHE) published this week, more and more people are not using e-cigarettes to quit traditional smoking due to fears about the harm the former cause.

5 Mar 2020

Cannabis use more prevalent among pregnant women with depression

Cannabis use is much more common among pregnant women with depression and pregnant women with depression are more than 3 times more likely to use cannabis than those without depression, according to a new study at Columbia University Mailman School of Public Health.

3 Mar 2020

How cannabis interacts with medications

A new practice guideline published in the journal CMAJ in February 2020 describes five types of drug interactions possible with the use of cannabis. Cannabis is a plant-derived drug containing the psychoactive ingredient delta-9-tetrahydrocannabinol (THC) and non-psychoactive cannabidiol (CBD). These cannabinoids are broken down by the liver enzymes cytochrome P450 C(YP)34A, and CYP2CC9.

2 Mar 2020

Cases of poisoning attributed to manipulated cannabidiol liquids in e-cigarettes

The health risks of e-cigarettes have come into focus after the deaths of several “vapers” due to lung injury in the USA recently.

27 Feb 2020

McMaster researchers identify antibacterial compound made by cannabis plants

McMaster University researchers have identified an antibacterial compound made by cannabis plants that may serve as a lead for new drug development.

26 Feb 2020

Researchers uncover hidden antibiotic potential of cannabis compound

Public health agencies worldwide have identified antibiotic resistance of disease-causing bacteria as one of humanity's most critical challenges. However, scientists haven't discovered a new class of antibiotics in more than 30 years.

26 Feb 2020

Research looks at prenatal cannabis use

More and more, pregnant women today are using cannabis, which is mostly for relieving stress and coping with mood changes. However, the risk associated with this for pregnant women who have mental ill-health or trauma is mostly unexplored.

19 Feb 2020

Common human gene variant linked to THC reward in adolescent females

A common variation in a human gene that affects the brain's reward processing circuit increases vulnerability to the rewarding effects of the main psychoactive ingredient of cannabis in adolescent females, but not males, according to preclinical research by Weill Cornell Medicine investigators.

12 Feb 2020